Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform

Ko, A. H., Kim, K.-P., Siveke, J. T., Lopez, C. D., Lacy, J., O’Reilly, E. M., Macarulla, T., Manji, G. A., Lee, J., Ajani, J., Alsina Maqueda, M., Rha, S.-Y., Lau, J., Al-Sakaff, N., Allen, S., Lu, D., Shemesh, C. S., Gan, X., Cha, E., & Oh, D.-Y. (2023). Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform. The Oncologist, 28(6), 553-e472. https://doi.org/10.1093/oncolo/oyad022
Authors:
Andrew H Ko
Kyu-Pyo Kim
Jens T Siveke
Charles D Lopez
Jill Lacy
Eileen M O'Reilly
Teresa Macarulla
Gulam A Manji
Jeeyun Lee
Jaffer Ajani
Maria Alsina Maqueda
Sun-Young Rha
Janet Lau
Nedal Al-Sakaff
Simon Allen
Danny Lu
Colby S Shemesh
Xinxin Gan
Edward Cha
Do-Youn Oh
Affiliated Authors:
Gulam A Manji
Author Keywords:
basket study
combination therapy
gastric cancer
hyaluronan
immunotherapy
pancreatic cancer
pd-l1
proof of concept
Publication Type:
Article
Unique ID:
10.1093/oncolo/oyad022
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: